Clinical trial / 2013
Higher nut consumption was associated with lower mortality in high-risk adults.
An analysis of 7,216 participants in the PREDIMED trial evaluated nut intake over a median follow-up of 4.8 years. Compared with non-consumers, individuals consuming more than three servings of nuts weekly had a 39% lower risk of total mortality (HR 0.61; 95% CI 0.45 to 0.83). Nut consumption was also linked to reduced risk of cardiovascular and cancer death, with the lowest overall mortality observed among nut group participants consuming this amount.
- Study type
- Secondary analysis of a randomized controlled trial
- Who was studied
- 7,216 adults aged 55 to 80 years at high cardiovascular risk, Spain
- What was measured
- all-cause, cardiovascular, and cancer mortality
THE PAPER
Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial.
Guasch-Ferré M, Bulló M, Martínez-González MÁ, Ros E, Corella D, Estruch R, Fitó M, Arós F, Wärnberg J, Fiol M, Lapetra J, Vinyoles E, Lamuela-Raventós RM, Serra-Majem L, Pintó X, Ruiz-Gutiérrez V, Basora J, Salas-Salvadó J, PREDIMED study group. BMC Med, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.